{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T07:56:16Z","timestamp":1722066976001},"reference-count":30,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.8008","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T10:02:09Z","timestamp":1568628129000},"source":"Crossref","is-referenced-by-count":5,"title":["Aspects concerning patient adherence to anti\u2011TNF\u03b1 therapy in psoriasis: A decade of clinical experience"],"prefix":"10.3892","author":[{"given":"Madalina","family":"Mocanu","sequence":"first","affiliation":[{"name":"Dermatology Clinic, Railways University Hospital Iasi, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700506 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela\u2011Paula","family":"Toader","sequence":"additional","affiliation":[{"name":"Dermatology Clinic, Railways University Hospital Iasi, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700506 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Rezus","sequence":"additional","affiliation":[{"name":"Rheumatology Clinic, University Rehabilitation Hospital, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Taranu","sequence":"additional","affiliation":[{"name":"Dermatology Clinic, Railways University Hospital Iasi, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700506 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"key":"key20200713101600_b1-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.disamonth.2018.06.001","article-title":"Biologics for the primary care physician: Review and treatment of psoriasis","volume":"65","author":"Schadler","year":"2019","journal-title":"Dis Mon"},{"key":"key20200713101600_b2-etm-0-0-8008","first-page":"1191","article-title":"In vivo imaging techniques for psoriatic lesions","volume":"55","author":"C\u0103runtu","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"key20200713101600_b3-etm-0-0-8008","first-page":"1241","article-title":"Assessment of dermal papillary and microvascular parameters in psoriasis vulgaris using in vivo reflectance confocal microscopy","volume":"15","author":"Batani","year":"2018","journal-title":"Exp Ther Med"},{"key":"key20200713101600_b4-etm-0-0-8008","first-page":"766","article-title":"Investigation relevance of methotrexate polyglutamates in biological systems by high performance liquid chromatography","volume":"66","author":"Negrei","year":"2015","journal-title":"Rev Chim"},{"key":"key20200713101600_b5-etm-0-0-8008","first-page":"767","article-title":"Acitretin treatment in psoriasis may influence the cell membrane fluidity","volume":"60","author":"Negrei","year":"2012","journal-title":"Farmacia"},{"key":"key20200713101600_b6-etm-0-0-8008","first-page":"607","article-title":"Qualitative and quantitative determination of methotrexate polyglutamates in erythrocytes by high performance liquid chromatography","volume":"66","author":"Negrei","year":"2015","journal-title":"Rev Chim"},{"key":"key20200713101600_b7-etm-0-0-8008","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: A network meta-analysis","volume":"12","author":"Sbidian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713101600_b8-etm-0-0-8008","first-page":"57","article-title":"Biosimilars: An update on clinical trials (review of published and ongoing studies","volume":"25","author":"Olteanu","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"key20200713101600_b9-etm-0-0-8008","first-page":"918","article-title":"Original clinical experience and approach to treatment study with interleukine 12\/23 inhibitor in moderate-to-severe psoriasis patients","volume":"64","author":"Olteanu","year":"2016","journal-title":"Farmacia"},{"key":"key20200713101600_b10-etm-0-0-8008","first-page":"163","article-title":"Perception of adherence to treatment among patients with cardiovascular risk factors","volume":"30","author":"Zambrano","year":"2012","journal-title":"Rev Fac Nac Salud Publica"},{"key":"key20200713101600_b11-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1097\/MJT.0000000000000560","article-title":"Metoprolol-associated onset of psoriatic arthropathy","volume":"24","author":"Tatu","year":"2017","journal-title":"Am J Ther"},{"key":"key20200713101600_b12-etm-0-0-8008","unstructured":"SabateEAdherence to Long-Term Therapies: Evidence for ActionWorld Health OrganizationGeneva2003https:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_report\/en\/"},{"key":"key20200713101600_b13-etm-0-0-8008","first-page":"704","article-title":"Assessment of some oxidative stress parameters in methotrexate treated psoriasis patients","volume":"62","author":"Boda","year":"2014","journal-title":"Farmacia"},{"key":"key20200713101600_b14-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.clindermatol.2007.10.024","article-title":"Economic considerations in psoriasis management","volume":"26","author":"Radtke","year":"2008","journal-title":"Clin Dermatol"},{"key":"key20200713101600_b15-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ajd.12294","article-title":"Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective","volume":"57","author":"Ross","year":"2016","journal-title":"Australas J Dermatol"},{"key":"key20200713101600_b16-etm-0-0-8008","first-page":"189","article-title":"Disease and treatment burden of psoriasis: Examining the impact of biologics","volume":"10","author":"Raval","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"key20200713101600_b17-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2340\/00015555-2011","article-title":"Treatment satisfaction of patients with psoriasis","volume":"95","author":"Schaarschmidt","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"key20200713101600_b18-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/jdv.14178","article-title":"Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: The importance of physician-patient interaction and communication","volume":"31","author":"Zschocke","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20200713101600_b19-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.jaad.2016.01.048","article-title":"Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population","volume":"74","author":"Doshi","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key20200713101600_b20-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/1346-8138.12353","article-title":"Drug survival rates in patients with psoriasis after treatment with biologics","volume":"40","author":"Umezawa","year":"2013","journal-title":"J Dermatol"},{"key":"key20200713101600_b21-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1365-2133.2011.10213.x","article-title":"Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris","volume":"164","author":"Gniadecki","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20200713101600_b22-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jaad.2015.04.023","article-title":"Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study","volume":"73","author":"Kim","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key20200713101600_b23-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key20200713101600_b24-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0001-7310(08)74739-2","article-title":"Clinical experience with etanercept in the treatment of psoriasis","volume":"99","author":"Mart\u00edn","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"key20200713101600_b25-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4103\/0019-5154.139859","article-title":"Biologics in dermatology: An integrated review","volume":"59","author":"Sehgal","year":"2014","journal-title":"Indian J Dermatol"},{"key":"key20200713101600_b26-etm-0-0-8008","doi-asserted-by":"crossref","first-page":"672","DOI":"10.37358\/MP.18.4.5110","article-title":"Curcumin-extraction, physical and chemical analysis, formulas and control. Basic methods for further research","volume":"55","author":"Niculet","year":"2018","journal-title":"Mater Plast"},{"key":"key20200713101600_b27-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jamadermatol.2019.0106","article-title":"Using complementary and alternative medicine for the treatment of psoriasis: A step in the right direction","volume":"155","author":"Nwabudike","year":"2019","journal-title":"JAMA Dermatol"},{"key":"key20200713101600_b28-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2217\/bmm.14.76","article-title":"Proteomics focusing on immune markers in psoriatic arthritis","volume":"9","author":"C\u0103runtu","year":"2015","journal-title":"Biomarkers Med"},{"key":"key20200713101600_b29-etm-0-0-8008","first-page":"1004","article-title":"In vivo confocal laser scanning microscopy imaging of skin inflammation: Clinical applications and research directions","volume":"17","author":"Ilie","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20200713101600_b30-etm-0-0-8008","doi-asserted-by":"publisher","first-page":"105950","DOI":"10.1155\/2014\/105950","article-title":"Stress-induced mast cell activation in glabrous and hairy skin","volume":"2014","author":"C\u0103runtu","year":"2014","journal-title":"Mediators Inflamm"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:16:09Z","timestamp":1594631769000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.8008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.8008","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]}}}